Xenetic Biosciences Announces Full Year 2013 Financial Results And Business Update
4/16/2014 9:06:52 AM
LEXINGTON, Mass., April 16, 2014 (GLOBE NEWSWIRE) -- Xenetic BioSciences (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel orphan oncology therapeutics, today reported financial results for the year-ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by